Clinical application of axillary reverse mapping in patients with breast cancer: A systematic review and meta-analysis
Open Access
- 1 October 2020
- journal article
- review article
- Published by Elsevier in The Breast
- Vol. 53, 189-200
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81101180, 81071282)
This publication has 45 references indexed in Scilit:
- Sentinel Lymph Node Surgery After Neoadjuvant Chemotherapy in Patients With Node-Positive Breast CancerJAMA, 2013
- Axillary Reverse Mapping: A Prospective Study in Women with Clinically Node Negative and Node Positive Breast CancerAnnals of Surgical Oncology, 2013
- The Efficacy of Arm Node Preserving Surgery Using Axillary Reverse Mapping for Preventing Lymphedema in Patients with Breast CancerJournal of Breast Cancer, 2012
- The Cochrane Collaboration's tool for assessing risk of bias in randomised trialsBMJ, 2011
- Safety study of axillary reverse mapping in the surgical treatment for breast cancer patientsJournal of Cancer Research and Clinical Oncology, 2011
- Axillary Dissection vs No Axillary Dissection in Women With Invasive Breast Cancer and Sentinel Node MetastasisJAMA, 2011
- A phase I study to assess the feasibility and oncologic safety of axillary reverse mapping in breast cancer patientsCancer, 2010
- Extensive Nodal Disease May Impair Axillary Reverse Mapping in Patients With Breast CancerJournal of Clinical Oncology, 2009
- Axillary reverse mapping for breast cancerBreast Cancer Research and Treatment, 2009
- Simultaneous two-color spectral fluorescence lymphangiography with near infrared quantum dots to map two lymphatic flows from the breast and the upper extremityBreast Cancer Research and Treatment, 2006